| (+)-Columbianetin |
|
|
|
|
|
|
|
99.04% |
| (+)-Erinacin A |
|
|
|
|
|
|
|
99.81% |
| (+)-Isomenthone |
|
|
|
|
|
|
|
99.13% |
| (-)-Syringaresinol |
|
|
|
|
|
|
|
99.93% |
| (2S)-OMPT |
|
|
|
|
|
|
|
|
| (2S)-OMPT triethylamine, in ethanol:chloroform (1:1), 98% |
|
|
|
|
|
|
|
99.0% |
| (3R,10R,14aS)-AZD4625 |
|
|
|
|
|
|
|
98.00% |
| (3S)-Tanzisertib hydrochloride |
|
|
|
|
|
|
|
|
| (aS)-PH-797804 |
|
|
|
|
|
|
|
|
| (E)-Osmundacetone |
|
|
|
|
|
|
|
99.81% |
| (E/Z)-Afatinib |
|
|
|
|
|
|
|
99.98% |
| (R)-Afatinib |
|
|
|
|
|
|
|
|
| (R)-STU104 |
|
|
|
|
|
|
|
99.91% |
| (R)-STU104-d6 |
|
|
|
|
|
|
|
99.90% |
| (S)-IP-DK143 |
|
|
|
|
|
|
|
|
| (Z)-Tetradec-7-en-1-ol |
|
|
|
|
|
|
|
|
| (±)-Iroxanadine |
|
|
|
|
|
|
|
|
| Tetramethyluric acid |
|
|
|
|
|
|
|
99.63% |
| 10-Methoxy-canthin-6-one |
|
|
|
|
|
|
|
98.71% |
| 12(S)-HETE |
|
|
|
|
|
|
|
99.10% |
| 12(S)-HETE-d8 |
|
|
|
|
|
|
|
|
| 12-Oxo phytodienoic acid |
|
|
|
|
|
|
|
|
| 12-Oxo phytodienoic acid (≥90%) |
|
|
|
|
|
|
|
92.2% |
| 18:0-22:6 DG |
|
|
|
|
|
|
|
99% |
| 2"-O-Galloylhyperin |
|
|
|
|
|
|
|
99.57% |
| 2"-O-Galloylhyperin (Standard) |
|
|
|
|
|
|
|
|
| 2,4-Dinitrobenzenesulfonic acid sodium salt |
|
|
|
|
|
|
|
99.98% |
| 2,5-Dimethylcyclohexanol |
|
|
|
|
|
|
|
99.88% |
| 2-Oleoxyphenethyl phosphocholin |
|
|
|
|
|
|
|
|
| 2-Phenylacetamide |
|
|
|
|
|
|
|
99.92% |
| 2-Stearoxyphenethyl phosphocholin |
|
|
|
|
|
|
|
|
| Phenylhydroquinone |
|
|
|
|
|
|
|
99.21% |
| 23-Hydroxybetulinic acid |
|
|
|
|
|
|
|
99.44% |
| 3′,4′,7-Trihydroxyflavone |
|
|
|
|
|
|
|
99.04% |
| 3′-O-Demethyl-4′-N-demethyl-4′-N-acetyl-4′-epi-staurosporine |
|
|
|
|
|
|
|
|
| Gallic aldehyde |
|
|
|
|
|
|
|
99.92% |
| 3-AP-Me |
|
|
|
|
|
|
|
|
| 3-Fluoro-desmethyl-cabozantinib |
|
|
|
|
|
|
|
|
| 3-Hydroxybenzaldehyde |
|
|
|
|
|
|
|
99.89% |
| Deoxysappanone B |
|
|
|
|
|
|
|
|
| 4′-Hydroxywogonin |
|
|
|
|
|
|
|
98.22% |
| 4-Hydroxy-3-butylphthalide |
|
|
|
|
|
|
|
|
| 4-Hydroxylonchocarpin |
|
|
|
|
|
|
|
98.95% |
| 5-Hydroxy-6,7-dimethoxyflavone |
|
|
|
|
|
|
|
|
| 5-O-Methylvisammioside |
|
|
|
|
|
|
|
99.90% |
| 6,8-Diprenylorobol |
|
|
|
|
|
|
|
98.40% |
| 6-Demethoxytangeretin |
|
|
|
|
|
|
|
99.37% |
| 6-Methoxyflavone |
|
|
|
|
|
|
|
99.73% |
| Oxidopamine hydrobromide |
|
|
|
|
|
|
|
99.42% |
| Oxidopamine hydrochloride |
|
|
|
|
|
|
|
98.97% |
| 7,4'-Dimethoxy-3-hydroxyflavone |
|
|
|
|
|
|
|
|
| 7-Ketocholesterol |
|
|
|
|
|
|
|
99.87% |
| 7-Methylsulfinylheptyl isothiocyanate |
|
|
|
|
|
|
|
|
| A2073 |
|
|
|
|
|
|
|
|
| Ac4ManNAz |
|
|
|
|
|
|
|
99.94% |
| Acetoxycycloheximide |
|
|
|
|
|
|
|
|
| Acumapimod |
|
|
|
|
|
|
|
99.68% |
| Adezmapimod |
|
|
|
|
|
|
|
99.93% |
| Adezmapimod hydrochloride |
|
|
|
|
|
|
|
99.37% |
| AF-45 |
|
|
|
|
|
|
|
|
| AKP-001 |
|
|
|
|
|
|
|
|
| Akt/NF-κB/MAPK-IN-1 |
|
|
|
|
|
|
|
|
| AL 8697 |
|
|
|
|
|
|
|
99.92% |
| AL-8810 |
|
|
|
|
|
|
|
99.0% |
| ALR2-IN-9 |
|
|
|
|
|
|
|
|
| AMC-04 |
|
|
|
|
|
|
|
98.48% |
| AMG-47a |
|
|
|
|
|
|
|
99.19% |
| AMG-548 |
|
|
|
|
|
|
|
98.28% |
| AMG-548 dihydrochloride |
|
|
|
|
|
|
|
99.86% |
| AMG-548 hydrochloride |
|
|
|
|
|
|
|
|
| AMPK-IN-5 |
|
|
|
|
|
|
|
|
| Andrograpanin |
|
|
|
|
|
|
|
99.89% |
| Antcin K |
|
|
|
|
|
|
|
|
| Anti-CD146 Antibody (AA98) |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 100 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 102 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 116 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 33 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 35 |
|
|
|
|
|
|
|
99.77% |
| Anti-inflammatory agent 66 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 7 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 72 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 74 |
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 99 |
|
|
|
|
|
|
|
|
| Anti-osteoporosis agent-11 |
|
|
|
|
|
|
|
|
| Anti-osteoporosis agent-8 |
|
|
|
|
|
|
|
|
| Antiangiogenic agent 3 |
|
|
|
|
|
|
|
|
| Anticancer agent 319 |
|
|
|
|
|
|
|
|
| Antidesmone |
|
|
|
|
|
|
|
|
| Antifungal agent 18 |
|
|
|
|
|
|
|
98.08% |
| Antiproliferative agent-57 |
|
|
|
|
|
|
|
|
| Apoptosis inducer 35 |
|
|
|
|
|
|
|
|
| Apoptosis inducer 53 |
|
|
|
|
|
|
|
|
| Apoptosis/necroptosis inducer 1 |
|
|
|
|
|
|
|
|
| AR420626 |
|
|
|
|
|
|
|
98.40% |
| Arnicolide B |
|
|
|
|
|
|
|
|
| Artocarpesin |
|
|
|
|
|
|
|
|
| AS1940477 |
|
|
|
|
|
|
|
|
| ASK1-IN-1 |
|
|
|
|
|
|
|
98.74% |
| ASK1-IN-12 |
|
|
|
|
|
|
|
|
| Aspartyl-alanyl-diketopiperazine |
|
|
|
|
|
|
|
98.87% |
| Aspirin calcium |
|
|
|
|
|
|
|
|
| Aspirin lithium |
|
|
|
|
|
|
|
|
| Atraric acid |
|
|
|
|
|
|
|
99.97% |
| ATX inhibitor 26 |
|
|
|
|
|
|
|
|
| Auriculasin |
|
|
|
|
|
|
|
98.54% |
| Autotaxin-IN-8 |
|
|
|
|
|
|
|
|
| AW-814141 |
|
|
|
|
|
|
|
|
| AZ14289671 |
|
|
|
|
|
|
|
|
| AZD 6703 |
|
|
|
|
|
|
|
|
| AZD4625 |
|
|
|
|
|
|
|
98.44% |
| AZD7624 |
|
|
|
|
|
|
|
98.09% |
| B-Raf IN 19 |
|
|
|
|
|
|
|
|
| Batiraxcept |
|
|
|
|
|
|
|
99.91% |
| BChE/p38-α MAPK-IN-1 |
|
|
|
|
|
|
|
|
| BChE/p38-α MAPK-IN-2 |
|
|
|
|
|
|
|
|
| Benzo[a]pyrene diol epoxide |
|
|
|
|
|
|
|
|
| Benzyl salicylate |
|
|
|
|
|
|
|
99.78% |
| Benzyl salicylate-d4 |
|
|
|
|
|
|
|
99.01% |
| BI-3406 |
|
|
|
|
|
|
|
99.95% |
| BIRB-1017 |
|
|
|
|
|
|
|
|
| BLT1-IN-1 |
|
|
|
|
|
|
|
|
| BMS-561392 |
|
|
|
|
|
|
|
|
| BMS-561392 formate |
|
|
|
|
|
|
|
99.13% |
| BMS-582949 |
|
|
|
|
|
|
|
|
| BMS-582949 hydrochloride |
|
|
|
|
|
|
|
98.90% |
| BMS-626531 |
|
|
|
|
|
|
|
|
| BMS-751324 |
|
|
|
|
|
|
|
|
| BRL-44408 |
|
|
|
|
|
|
|
|
| BRL-44408 maleate |
|
|
|
|
|
|
|
99.0% |
| Broussonin E |
|
|
|
|
|
|
|
98.11% |
| BS148 |
|
|
|
|
|
|
|
|
| BSJ-04-122 |
|
|
|
|
|
|
|
99.88% |
| BuChE-IN-23 |
|
|
|
|
|
|
|
|
| Buloxibutid |
|
|
|
|
|
|
|
98.94% |
| Buloxibutid hydrochloride |
|
|
|
|
|
|
|
|
| Butyzamide |
|
|
|
|
|
|
|
99.83% |
| Butyzamide |
|
|
|
|
|
|
|
|
| C16-PAF |
|
|
|
|
|
|
|
99.15% |
| Calebin A |
|
|
|
|
|
|
|
98.0% |
| Callistephin chloride |
|
|
|
|
|
|
|
98.31% |
| Candidalysin |
|
|
|
|
|
|
|
99.81% |
| Candidone |
|
|
|
|
|
|
|
|
| Cannabisin D |
|
|
|
|
|
|
|
|
| Cannflavin B |
|
|
|
|
|
|
|
98.14% |
| Carboxyamidotriazole |
|
|
|
|
|
|
|
99.82% |
| Casein kinase 1δ-IN-27 |
|
|
|
|
|
|
|
|
| Casein kinase 1δ-IN-29 |
|
|
|
|
|
|
|
|
| Casein kinase 1δ-IN-31 |
|
|
|
|
|
|
|
|
| Casuarinin |
|
|
|
|
|
|
|
98.24% |
| Catenarin |
|
|
|
|
|
|
|
|
| Catestatin sCst |
|
|
|
|
|
|
|
|
| Cathepsin G |
|
|
|
|
|
|
|
|
| CB1R antagonist 2 |
|
|
|
|
|
|
|
|
| CBS-3408 |
|
|
|
|
|
|
|
|
| CBS-3595 |
|
|
|
|
|
|
|
|
| Ceramide (Egg) |
|
|
|
|
|
|
|
99% |
| Cernuumolide J |
|
|
|
|
|
|
|
|
| CGH2466 dihydrochloride |
|
|
|
|
|
|
|
|
| Chemerin15 |
|
|
|
|
|
|
|
99.65% |
| Chloranthalactone B |
|
|
|
|
|
|
|
|
| CHMFL-ABL-053 |
|
|
|
|
|
|
|
|
| Chromium picolinate |
|
|
|
|
|
|
|
99.76% |
| Chuanbeinone |
|
|
|
|
|
|
|
|
| Cichoriin |
|
|
|
|
|
|
|
99.9% |
| CK1-IN-1 |
|
|
|
|
|
|
|
99.19% |
| CK1δ-IN-9 |
|
|
|
|
|
|
|
|
| CK37 |
|
|
|
|
|
|
|
|
| CLP-d2 |
|
|
|
|
|
|
|
|
| Cm-CATH2 |
|
|
|
|
|
|
|
|
| CMIT/MIT (14.5% in water) |
|
|
|
|
|
|
|
14.36% |
| CN009543V |
|
|
|
|
|
|
|
99.37% |
| COVA208 |
|
|
|
|
|
|
|
|
| CP-944629 |
|
|
|
|
|
|
|
|
| CP-99994 |
|
|
|
|
|
|
|
|
| CP-99994 hydrochloride |
|
|
|
|
|
|
|
|
| Creosol |
|
|
|
|
|
|
|
99.82% |
| Creosol-d4 |
|
|
|
|
|
|
|
|
| Cryptolepine |
|
|
|
|
|
|
|
|
| CT-1 |
|
|
|
|
|
|
|
99.90% |
| Cubebin |
|
|
|
|
|
|
|
|
| Cudraflavone B |
|
|
|
|
|
|
|
|
| Cyanidin 3,5-diglucoside chloride |
|
|
|
|
|
|
|
99.44% |
| Cyanidin-3-O-arabinoside |
|
|
|
|
|
|
|
95.71% |
| Cyclocurcumin |
|
|
|
|
|
|
|
99.48% |
| Cyclotraxin B |
|
|
|
|
|
|
|
99.78% |
| d-T101 peptide |
|
|
|
|
|
|
|
|
| D-Psicose |
|
|
|
|
|
|
|
99.99% |
| D228 |
|
|
|
|
|
|
|
99.77% |
| Daphnegiravone D |
|
|
|
|
|
|
|
|
| Darizmetinib |
|
|
|
|
|
|
|
99.94% |
| dASK1-VHL |
|
|
|
|
|
|
|
|
| DB-10 |
|
|
|
|
|
|
|
|
| Dehydrocorydaline (hydroxyl) |
|
|
|
|
|
|
|
99.52% |
| Dehydrodiisoeugenol-d4 |
|
|
|
|
|
|
|
|
| Deltafluorine |
|
|
|
|
|
|
|
|
| Demethyleneberberine chloride |
|
|
|
|
|
|
|
98.90% |
| Desipramine |
|
|
|
|
|
|
|
|
| DHW-221 |
|
|
|
|
|
|
|
|
| Dilmapimod tosylate |
|
|
|
|
|
|
|
|
| Diphenylcyclopropenone |
|
|
|
|
|
|
|
99.88% |
| Diprovocim |
|
|
|
|
|
|
|
98.82% |
| DK2403 |
|
|
|
|
|
|
|
98.24% |
| DL-Syringaresinol |
|
|
|
|
|
|
|
96% |
| DNH28 |
|
|
|
|
|
|
|
|
| Dual Cathepsin L/JAK-IN-1 |
|
|
|
|
|
|
|
98.47% |
| EF24 |
|
|
|
|
|
|
|
99.34% |
| EGF-R (661-681) T669 Peptide |
|
|
|
|
|
|
|
|
| EGFR kinase-IN-8 |
|
|
|
|
|
|
|
|
| EGFR-IN-119 |
|
|
|
|
|
|
|
|
| EGFR-IN-154 |
|
|
|
|
|
|
|
|
| EGFR-IN-173 |
|
|
|
|
|
|
|
|
| EGFR-IN-209 |
|
|
|
|
|
|
|
|
| Emodin-8-glucoside |
|
|
|
|
|
|
|
99.35% |
| Emprumapimod |
|
|
|
|
|
|
|
99.39% |
| Emprumapimod hydrochloride |
|
|
|
|
|
|
|
98.0% |
| Enzyme modulator-1 |
|
|
|
|
|
|
|
|
| EO 1428 |
|
|
|
|
|
|
|
99.65% |
| Ephemeranthol A |
|
|
|
|
|
|
|
|
| ERK2/p38α MAPK-IN-1 |
|
|
|
|
|
|
|
|
| Erufosine |
|
|
|
|
|
|
|
|
| ETI41 |
|
|
|
|
|
|
|
|
| ETI60 |
|
|
|
|
|
|
|
99.51% |
| Eupalestin |
|
|
|
|
|
|
|
|
| Evariquinone |
|
|
|
|
|
|
|
|
| EW-7195 |
|
|
|
|
|
|
|
98.84% |
| Exarafenib |
|
|
|
|
|
|
|
99.68% |
| Ferroptosis inducer-7 |
|
|
|
|
|
|
|
|
| FGFR-IN-23 |
|
|
|
|
|
|
|
|
| FGFR-IN-24 |
|
|
|
|
|
|
|
|
| FGFR-IN-28 |
|
|
|
|
|
|
|
|
| FgGpmk1-IN-1 |
|
|
|
|
|
|
|
|
| FIP22 |
|
|
|
|
|
|
|
98.53% |
| FKA-9i |
|
|
|
|
|
|
|
|
| FLT3-IN-32 hydrochloride |
|
|
|
|
|
|
|
|
| Fluazinam |
|
|
|
|
|
|
|
99.36% |
| FMF-06-098-1 |
|
|
|
|
|
|
|
98.77% |
| FR 167653 |
|
|
|
|
|
|
|
99.87% |
| FR 167653 free base |
|
|
|
|
|
|
|
|
| FS-694 |
|
|
|
|
|
|
|
|
| FTI 276 |
|
|
|
|
|
|
|
|
| FTI 276 TFA |
|
|
|
|
|
|
|
98.31% |
| Fumaric acid-13C2 |
|
|
|
|
|
|
|
99.9% |
| G721-0282 |
|
|
|
|
|
|
|
99.96% |
| Gamma-glutamylcysteine ammonium |
|
|
|
|
|
|
|
|
| Ganglioside GM2 |
|
|
|
|
|
|
|
98.0% |
| Ganoderterpene A |
|
|
|
|
|
|
|
|
| GDC-3280 |
|
|
|
|
|
|
|
98.82% |
| GFH018 |
|
|
|
|
|
|
|
98.59% |
| GFH018 methylbenzenesulfonate |
|
|
|
|
|
|
|
|
| Ginsenoside F2 |
|
|
|
|
|
|
|
99.92% |
| GK-136901 |
|
|
|
|
|
|
|
|
| GLPG0259 |
|
|
|
|
|
|
|
99.63% |
| Glucagon receptor antagonist-8 |
|
|
|
|
|
|
|
|
| Gossypetin |
|
|
|
|
|
|
|
99.0% |
| GSI526 |
|
|
|
|
|
|
|
|
| GSK1995057 |
|
|
|
|
|
|
|
99.09% |
| Gy-CATH |
|
|
|
|
|
|
|
|
| Halociline |
|
|
|
|
|
|
|
|
| HDAC9-IN-1 |
|
|
|
|
|
|
|
95.13% |
| HE4-1 leech peptide |
|
|
|
|
|
|
|
|
| Hecubine |
|
|
|
|
|
|
|
|
| Hemocyanin |
|
|
|
|
|
|
|
95% |
| Hexamethylene bisacetamide |
|
|
|
|
|
|
|
99.56% |
| Hispidin |
|
|
|
|
|
|
|
99.85% |
| Histamine dihydrochloride |
|
|
|
|
|
|
|
99.92% |
| Histamine-13C5, 15N3 |
|
|
|
|
|
|
|
|
| Histamine-15N3 |
|
|
|
|
|
|
|
|
| Histamine-d4 |
|
|
|
|
|
|
|
|
| HT-2 Toxin |
|
|
|
|
|
|
|
99.77% |
| HVF18-a3-d |
|
|
|
|
|
|
|
|
| Hydrangenol |
|
|
|
|
|
|
|
99.62% |
| Hydrostatin-TL1 |
|
|
|
|
|
|
|
|
| ICA-1S |
|
|
|
|
|
|
|
|
| IDB-001 |
|
|
|
|
|
|
|
99.48% |
| IMC-EB10 |
|
|
|
|
|
|
|
98% |
| Inflachromene |
|
|
|
|
|
|
|
99.76% |
| INH2BP |
|
|
|
|
|
|
|
|
| iNOs-IN-6 |
|
|
|
|
|
|
|
|
| Inotodiol |
|
|
|
|
|
|
|
98.29% |
| Iroxanadine |
|
|
|
|
|
|
|
|
| Iroxanadine hydrobromide |
|
|
|
|
|
|
|
|
| Iroxanadine hydrochloride |
|
|
|
|
|
|
|
|
| Iroxanadine sulfate |
|
|
|
|
|
|
|
|
| IS20 |
|
|
|
|
|
|
|
99.85% |
| ISAM-CG557 |
|
|
|
|
|
|
|
|
| Isobavachin |
|
|
|
|
|
|
|
99.88% |
| Isocryptotanshinone |
|
|
|
|
|
|
|
98% |
| Isocucurbitacin B |
|
|
|
|
|
|
|
98.98% |
| Isodorsmanin A |
|
|
|
|
|
|
|
|
| Isomahanine |
|
|
|
|
|
|
|
|
| Isosalvianolic acid C |
|
|
|
|
|
|
|
|
| Isostrictiniin |
|
|
|
|
|
|
|
|
| ITX5061 |
|
|
|
|
|
|
|
99.69% |
| ITX5061 free base |
|
|
|
|
|
|
|
|
| ITZ-1 |
|
|
|
|
|
|
|
|
| J-1149 |
|
|
|
|
|
|
|
|
| JD123 |
|
|
|
|
|
|
|
90.0% |
| JE-133 |
|
|
|
|
|
|
|
|
| JNJ-49095397 |
|
|
|
|
|
|
|
99.55% |
| JNK2/MKK7 PPI-IN-1 |
|
|
|
|
|
|
|
|
| JNK3 inhibitor-5 |
|
|
|
|
|
|
|
|
| JRN73958 |
|
|
|
|
|
|
|
|
| JX10 |
|
|
|
|
|
|
|
|
| JX401 |
|
|
|
|
|
|
|
|
| K-14585 |
|
|
|
|
|
|
|
|
| K882 |
|
|
|
|
|
|
|
|
| Kaempferol 3-O-(2G-glucosylrutinoside)-7-O-glucoside |
|
|
|
|
|
|
|
|
| KAI-11101 |
|
|
|
|
|
|
|
|
| KFP-H008 |
|
|
|
|
|
|
|
|
| KMS99220 |
|
|
|
|
|
|
|
99.48% |
| KRAS G12C-IN-77 |
|
|
|
|
|
|
|
|
| KRAS G12C-IN-78 |
|
|
|
|
|
|
|
|
| KRAS G12D-IN-30 |
|
|
|
|
|
|
|
99.38% |
| KRAS inhibitor-27 |
|
|
|
|
|
|
|
|
| KRAS-IN-55 |
|
|
|
|
|
|
|
|
| KRASG12C IN-16 |
|
|
|
|
|
|
|
|
| KW-2478 |
|
|
|
|
|
|
|
99.53% |
| KW-2478 hydrochloride |
|
|
|
|
|
|
|
|
| L-167307 |
|
|
|
|
|
|
|
|
| L-threo-Sphingosine |
|
|
|
|
|
|
|
|
| L-Quebrachitol |
|
|
|
|
|
|
|
99.51% |
| Lambertellin |
|
|
|
|
|
|
|
|
| LasB-IN-1 |
|
|
|
|
|
|
|
|
| Latanoprost acid |
|
|
|
|
|
|
|
98.77% |
| LC-MG-10 |
|
|
|
|
|
|
|
|
| LC-SF-14 |
|
|
|
|
|
|
|
|
| Liensinine perchlorate |
|
|
|
|
|
|
|
99.67% |
| Link N peptide |
|
|
|
|
|
|
|
99.62% |
| LL-Z1640-4 |
|
|
|
|
|
|
|
99.0% |
| LM9 |
|
|
|
|
|
|
|
|
| LNSMGQD |
|
|
|
|
|
|
|
99.92% |
| Lucidone |
|
|
|
|
|
|
|
|
| Lumichrome-d8 |
|
|
|
|
|
|
|
|
| LUT014 |
|
|
|
|
|
|
|
97.09% |
| Luvometinib |
|
|
|
|
|
|
|
99.94% |
| Luvometinib-d |
|
|
|
|
|
|
|
|
| LX-3 |
|
|
|
|
|
|
|
98.08% |
| LY-2624587 |
|
|
|
|
|
|
|
|
| LY456236 |
|
|
|
|
|
|
|
99.57% |
| LY456236 free base |
|
|
|
|
|
|
|
|
| LYRM03 |
|
|
|
|
|
|
|
|
| M802 |
|
|
|
|
|
|
|
|
| Maackiain |
|
|
|
|
|
|
|
99.83% |
| Macranthoin G |
|
|
|
|
|
|
|
|
| Malabaricone C |
|
|
|
|
|
|
|
99.46% |
| MAPK-IN-1 |
|
|
|
|
|
|
|
98.11% |
| MAPK-IN-2 |
|
|
|
|
|
|
|
99.66% |
| MAPK-IN-3 |
|
|
|
|
|
|
|
|
| MAPK-IN-4 |
|
|
|
|
|
|
|
|
| MAPK-IN-5 |
|
|
|
|
|
|
|
|
| MAPK-IN-6 |
|
|
|
|
|
|
|
|
| MAPK11 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk11 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk11 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| MAPK12 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk12 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk12 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| MAPK13 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk13 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk13 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| MAPK13-IN-1 |
|
|
|
|
|
|
|
98.88% |
| MAPK14 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk14 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Mapk14 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| MAT2A inhibitor 2 |
|
|
|
|
|
|
|
99.10% |
| Matairesinol |
|
|
|
|
|
|
|
98.78% |
| MBL-1 |
|
|
|
|
|
|
|
|
| MBP MAPK Substrate |
|
|
|
|
|
|
|
99.58% |
| MCB-294 |
|
|
|
|
|
|
|
|
| MCB-36 |
|
|
|
|
|
|
|
98.43% |
| MEK-IN-10 |
|
|
|
|
|
|
|
|
| Meptyldinocap |
|
|
|
|
|
|
|
99.91% |
| Methyl protodioscin |
|
|
|
|
|
|
|
99.67% |
| Methyl rosmarinate |
|
|
|
|
|
|
|
99.46% |
| Methylcarbamyl PAF C-8 |
|
|
|
|
|
|
|
|
| Mianserin-d3 |
|
|
|
|
|
|
|
|
| Migoprotafib |
|
|
|
|
|
|
|
98.81% |
| MJ210 |
|
|
|
|
|
|
|
|
| MJ33 |
|
|
|
|
|
|
|
|
| MJ33 lithium salt |
|
|
|
|
|
|
|
99.0% |
| MK2-IN-5 |
|
|
|
|
|
|
|
|
| MK2-IN-5 acetate |
|
|
|
|
|
|
|
99.64% |
| MKK6 SDTD Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
| MKK7-COV-9 |
|
|
|
|
|
|
|
97.34% |
| MKK7-JNK activator 1 |
|
|
|
|
|
|
|
99.89% |
| ML3403 |
|
|
|
|
|
|
|
99.28% |
| MptpB-IN-3 |
|
|
|
|
|
|
|
|
| MRS2690 |
|
|
|
|
|
|
|
|
| MRS2690 disodium |
|
|
|
|
|
|
|
|
| MSC 2032964A |
|
|
|
|
|
|
|
|
| MTBT |
|
|
|
|
|
|
|
99.61% |
| Multi-kinase-IN-11 |
|
|
|
|
|
|
|
|
| Muramyl dipeptide |
|
|
|
|
|
|
|
99.07% |
| Muramyl dipeptide-d3 |
|
|
|
|
|
|
|
|
| Murrayafoline A |
|
|
|
|
|
|
|
99.73% |
| MW-150 |
|
|
|
|
|
|
|
99.89% |
| MW-150 dihydrochloride dihydrate |
|
|
|
|
|
|
|
|
| MW-150 hydrochloride |
|
|
|
|
|
|
|
|
| MW108 hydrochloride |
|
|
|
|
|
|
|
|
| MyD88-IN-3 |
|
|
|
|
|
|
|
99.33% |
| N-(p-Coumaroyl) Serotonin |
|
|
|
|
|
|
|
99.03% |
| N-(p-Coumaroyl) Serotonin (Standard) |
|
|
|
|
|
|
|
|
| N-Acetyldehydroanonaine |
|
|
|
|
|
|
|
|
| N-Arachidonoyl-L-serine |
|
|
|
|
|
|
|
98% |
| N-Feruloyloctopamine |
|
|
|
|
|
|
|
99.91% |
| N-Acetylgalactosaminyltransferase 4 |
|
|
|
|
|
|
|
|
| N-Acetylmuramic acid |
|
|
|
|
|
|
|
99.9% |
| N-Methylparoxetine |
|
|
|
|
|
|
|
99.97% |
| Nalmefene |
|
|
|
|
|
|
|
99.94% |
| Nalmefene Sulfate-d3 |
|
|
|
|
|
|
|
|
| Naporafenib |
|
|
|
|
|
|
|
99.92% |
| Natsudaidain |
|
|
|
|
|
|
|
99.66% |
| NDs-IN-1 |
|
|
|
|
|
|
|
|
| Nedometinib |
|
|
|
|
|
|
|
98.09% |
| Neflamapimod |
|
|
|
|
|
|
|
99.32% |
| Neoeriocitrin |
|
|
|
|
|
|
|
99.97% |
| Neral |
|
|
|
|
|
|
|
97.87% |
| NF-κB/MAPK-IN-1 |
|
|
|
|
|
|
|
98.71% |
| NF-κB/MAPK-IN-2 |
|
|
|
|
|
|
|
|
| Nimustine |
|
|
|
|
|
|
|
|
| Nimustine hydrochloride |
|
|
|
|
|
|
|
99.00% |
| NJK14047 |
|
|
|
|
|
|
|
|
| Norbergenin |
|
|
|
|
|
|
|
98.31% |
| Norkurarinol |
|
|
|
|
|
|
|
|
| NR-11c |
|
|
|
|
|
|
|
99.75% |
| NR-7h |
|
|
|
|
|
|
|
96.88% |
| Nrf2 activator-23 |
|
|
|
|
|
|
|
|
| Nur77 antagonist 2 |
|
|
|
|
|
|
|
|
| Oleanolic acid 28-O-β-D-glucopyranoside |
|
|
|
|
|
|
|
99.42% |
| Oltipraz metabolite M2 |
|
|
|
|
|
|
|
|
| OR-1855 |
|
|
|
|
|
|
|
98.31% |
| Org 48762-0 |
|
|
|
|
|
|
|
99.99% |
| Org OD 02-0 |
|
|
|
|
|
|
|
99.7% |
| OVA-E1 peptide |
|
|
|
|
|
|
|
|
| OVA-E1 peptide TFA |
|
|
|
|
|
|
|
98.05% |
| Oxidized low density lipoprotein (Human) |
|
|
|
|
|
|
|
|
| Oxypeucedanin |
|
|
|
|
|
|
|
99.50% |
| p-Synephrine |
|
|
|
|
|
|
|
99.90% |
| P2L-003 |
|
|
|
|
|
|
|
|
| p38 Kinase inhibitor 4 |
|
|
|
|
|
|
|
|
| p38 Kinase inhibitor 5 |
|
|
|
|
|
|
|
|
| p38 Kinase inhibitor 7 |
|
|
|
|
|
|
|
|
| p38 Kinase inhibitor 8 |
|
|
|
|
|
|
|
|
| p38 Kinase-IN-9 |
|
|
|
|
|
|
|
|
| p38 MAP Kinase Inhibitor III |
|
|
|
|
|
|
|
98.77% |
| p38 MAP Kinase Inhibitor IV |
|
|
|
|
|
|
|
98.0% |
| p38 MAP Kinase Inhibitor Ⅵ |
|
|
|
|
|
|
|
98.0% |
| p38 MAP Kinase-IN-1 |
|
|
|
|
|
|
|
|
| p38 MAP Kinase-IN-2 |
|
|
|
|
|
|
|
|
| p38 MAP Kinase-IN-3 |
|
|
|
|
|
|
|
|
| p38 MAP Kinase-IN-4 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-1 |
|
|
|
|
|
|
|
99.71% |
| p38 MAPK-IN-10 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-11 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-2 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-3 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-4 |
|
|
|
|
|
|
|
98.69% |
| p38 MAPK-IN-6 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-7 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-8 |
|
|
|
|
|
|
|
|
| p38 MAPK-IN-9 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-1 |
|
|
|
|
|
|
|
99.71% |
| p38-α MAPK-IN-10 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-11 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-4 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-5 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-6 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-7 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-8 |
|
|
|
|
|
|
|
|
| p38-α MAPK-IN-9 |
|
|
|
|
|
|
|
|
| p38α inhibitor 1 |
|
|
|
|
|
|
|
98.91% |
| p38α inhibitor 2 |
|
|
|
|
|
|
|
98.33% |
| p38α inhibitor 3 |
|
|
|
|
|
|
|
99.82% |
| p38α inhibitor 4 |
|
|
|
|
|
|
|
|
| p38α inhibitor 5 |
|
|
|
|
|
|
|
98.69% |
| p38α inhibitor 6 |
|
|
|
|
|
|
|
|
| p38α inhibitor 7 |
|
|
|
|
|
|
|
|
| p38α inhibitor 8 |
|
|
|
|
|
|
|
|
| p38α ligand-1 |
|
|
|
|
|
|
|
98.94% |
| p38α MAPK/CK1δ inhibitor-1 |
|
|
|
|
|
|
|
|
| p38α-IN-10 |
|
|
|
|
|
|
|
|
| p38α-IN-11 |
|
|
|
|
|
|
|
|
| p38α-IN-12 |
|
|
|
|
|
|
|
|
| p38α-IN-13 |
|
|
|
|
|
|
|
|
| p38α-IN-9 |
|
|
|
|
|
|
|
|
| p38α-MK2-IN-1 |
|
|
|
|
|
|
|
|
| Pam2CSK4 |
|
|
|
|
|
|
|
|
| Pam2CSK4 TFA |
|
|
|
|
|
|
|
99.46% |
| Pamapimod |
|
|
|
|
|
|
|
99.71% |
| Pamapimod-d4 |
|
|
|
|
|
|
|
|
| pan-KRAS-IN-5 |
|
|
|
|
|
|
|
96.70% |
| Pan-RAS-IN-8 |
|
|
|
|
|
|
|
|
| Panaxcerol C |
|
|
|
|
|
|
|
|
| PAR2 modulator-1 |
|
|
|
|
|
|
|
|
| PD 169316 |
|
|
|
|
|
|
|
99.07% |
| PD-254552 |
|
|
|
|
|
|
|
|
| PD166326 |
|
|
|
|
|
|
|
99.99% |
| PDE1-IN-10 |
|
|
|
|
|
|
|
|
| PDE4-IN-26 |
|
|
|
|
|
|
|
|
| Pentadecanoic acid |
|
|
|
|
|
|
|
99.92% |
| Periplanetasin-4 |
|
|
|
|
|
|
|
|
| PeS-9 |
|
|
|
|
|
|
|
|
| Pestanoid A |
|
|
|
|
|
|
|
|
| Pexmetinib |
|
|
|
|
|
|
|
99.81% |
| PF-03715455 |
|
|
|
|
|
|
|
98.44% |
| PF-05381941 |
|
|
|
|
|
|
|
99.73% |
| PF-3644022 |
|
|
|
|
|
|
|
99.91% |
| PF-3644022 (Standard) |
|
|
|
|
|
|
|
|
| PF-719 |
|
|
|
|
|
|
|
99.52% |
| PH-797804 |
|
|
|
|
|
|
|
98.94% |
| Physalin A |
|
|
|
|
|
|
|
99.63% |
| Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside |
|
|
|
|
|
|
|
98.92% |
| Pipoxolan hydrochloride |
|
|
|
|
|
|
|
|
| Pleurocidin |
|
|
|
|
|
|
|
98.91% |
| PLK1/p38γ-IN-1 |
|
|
|
|
|
|
|
|
| PLS-123 |
|
|
|
|
|
|
|
|
| PMK1-IN-1 |
|
|
|
|
|
|
|
|
| Pongamol |
|
|
|
|
|
|
|
99.81% |
| PPIA-IN-1 |
|
|
|
|
|
|
|
96.90% |
| PQ-1 |
|
|
|
|
|
|
|
|
| PROTAC Bcl-xL degrader-4 |
|
|
|
|
|
|
|
|
| PROTAC BTK Degrader-13 |
|
|
|
|
|
|
|
|
| PROTAC HIF-1α degrader-2 |
|
|
|
|
|
|
|
|
| PROTAC HPK1 Degrader-3 |
|
|
|
|
|
|
|
|
| PRX-08066 |
|
|
|
|
|
|
|
97.46% |
| PRX-08066 maleate |
|
|
|
|
|
|
|
|
| PS-166276 |
|
|
|
|
|
|
|
|
| PSMα3 |
|
|
|
|
|
|
|
99.39% |
| PSMα3 TFA |
|
|
|
|
|
|
|
|
| Pterosin A |
|
|
|
|
|
|
|
94.07% |
| Q-Peptide |
|
|
|
|
|
|
|
99.46% |
| Quinalizarin |
|
|
|
|
|
|
|
97.23% |
| R 1487 |
|
|
|
|
|
|
|
|
| R-03201195 |
|
|
|
|
|
|
|
|
| R-130823 |
|
|
|
|
|
|
|
|
| R1-ICR-5 |
|
|
|
|
|
|
|
98.73% |
| R1487 Hydrochloride |
|
|
|
|
|
|
|
98.96% |
| Ralimetinib |
|
|
|
|
|
|
|
98.58% |
| Ralimetinib dimesylate |
|
|
|
|
|
|
|
99.97% |
| RANKL-IN-1 |
|
|
|
|
|
|
|
|
| RANKL-IN-2 |
|
|
|
|
|
|
|
|
| Raxofelast |
|
|
|
|
|
|
|
|
| RBC8 |
|
|
|
|
|
|
|
98.0% |
| rel-Latanoprost acid |
|
|
|
|
|
|
|
|
| rel-Talmapimod hydrochloride |
|
|
|
|
|
|
|
|
| RG100204 |
|
|
|
|
|
|
|
99.50% |
| RIPK1-IN-32 |
|
|
|
|
|
|
|
|
| RIPK2-IN-6 |
|
|
|
|
|
|
|
|
| RIPK2-IN-8 |
|
|
|
|
|
|
|
|
| RO3201195 |
|
|
|
|
|
|
|
99.77% |
| RO5068760 |
|
|
|
|
|
|
|
|
| Roxatidine |
|
|
|
|
|
|
|
98.25% |
| RP-220 |
|
|
|
|
|
|
|
|
| RPR-200765A methanesulfonate |
|
|
|
|
|
|
|
|
| RPR203494 |
|
|
|
|
|
|
|
|
| RWJ-67657 |
|
|
|
|
|
|
|
99.75% |
| Santamarine |
|
|
|
|
|
|
|
98.85% |
| Sappanone A |
|
|
|
|
|
|
|
99.87% |
| Saquinavir-13C6 |
|
|
|
|
|
|
|
|
| Satratoxin H |
|
|
|
|
|
|
|
99.7% |
| SB 202190 |
|
|
|
|
|
|
|
99.89% |
| SB 202190 hydrochloride |
|
|
|
|
|
|
|
99.60% |
| SB 202474 |
|
|
|
|
|
|
|
99.9% |
| SB 220025 |
|
|
|
|
|
|
|
99.90% |
| SB 220025 (tri(hydrochloride)) |
|
|
|
|
|
|
|
|
| SB 239063 |
|
|
|
|
|
|
|
99.15% |
| SB 242235 |
|
|
|
|
|
|
|
99.67% |
| SB 706504 |
|
|
|
|
|
|
|
|
| SB-204900 |
|
|
|
|
|
|
|
|
| SB-284851-BT |
|
|
|
|
|
|
|
|
| SB-747651A |
|
|
|
|
|
|
|
|
| SB-747651A dihydrochloride |
|
|
|
|
|
|
|
99.14% |
| SB-T-101141 |
|
|
|
|
|
|
|
|
| SC-68376 |
|
|
|
|
|
|
|
|
| SD 0006 |
|
|
|
|
|
|
|
98.22% |
| SD-169 |
|
|
|
|
|
|
|
99.17% |
| SDUY127 |
|
|
|
|
|
|
|
|
| Semaglutide (crude) |
|
|
|
|
|
|
|
77.53% |
| Semaglutide acetate |
|
|
|
|
|
|
|
99.96% |
| Semaglutide sodium |
|
|
|
|
|
|
|
|
| Semaglutide, Cy5 labeled |
|
|
|
|
|
|
|
|
| Semaglutide-d8 tetraTFA |
|
|
|
|
|
|
|
99.87% |
| Semapimod |
|
|
|
|
|
|
|
|
| Semapimod tetrahydrochloride |
|
|
|
|
|
|
|
99.18% |
| SF-9-2 |
|
|
|
|
|
|
|
|
| SH494 |
|
|
|
|
|
|
|
|
| SH543 |
|
|
|
|
|
|
|
|
| SHOC2-RAS PPI-IN-1 |
|
|
|
|
|
|
|
99.50% |
| Silybin B-d3 |
|
|
|
|
|
|
|
|
| SJF-8240 |
|
|
|
|
|
|
|
99.33% |
| SJFα |
|
|
|
|
|
|
|
99.61% |
| SJFδ |
|
|
|
|
|
|
|
|
| Skepinone-L |
|
|
|
|
|
|
|
99.79% |
| SKF-86002 |
|
|
|
|
|
|
|
99.91% |
| SKF-86002 dihydrochloride |
|
|
|
|
|
|
|
|
| SKLB646 |
|
|
|
|
|
|
|
|
| SL43 |
|
|
|
|
|
|
|
|
| SM-7368 |
|
|
|
|
|
|
|
99.77% |
| SMU-037 |
|
|
|
|
|
|
|
|
| SMU-14a |
|
|
|
|
|
|
|
|
| SMU-C68 |
|
|
|
|
|
|
|
|
| SMU-L11-R |
|
|
|
|
|
|
|
|
| SMU-R39 |
|
|
|
|
|
|
|
|
| Sotorasib racemate |
|
|
|
|
|
|
|
98.99% |
| SPA0355 |
|
|
|
|
|
|
|
99.54% |
| SR-302 |
|
|
|
|
|
|
|
98.51% |
| SR-318 |
|
|
|
|
|
|
|
98.17% |
| SR-3737 |
|
|
|
|
|
|
|
|
| SSK1 |
|
|
|
|
|
|
|
99.75% |
| ST-162 |
|
|
|
|
|
|
|
|
| Stigmasta-3,5-dien-7-one |
|
|
|
|
|
|
|
99.84% |
| Strictosamide |
|
|
|
|
|
|
|
99.94% |
| Suberic acid |
|
|
|
|
|
|
|
98.0% |
| Sudachitin |
|
|
|
|
|
|
|
|
| Sugiol |
|
|
|
|
|
|
|
99.88% |
| Swertianolin |
|
|
|
|
|
|
|
99.54% |
| SX 011 |
|
|
|
|
|
|
|
99.33% |
| TA-01 |
|
|
|
|
|
|
|
99.86% |
| TA-02 |
|
|
|
|
|
|
|
99.85% |
| TAK-715 |
|
|
|
|
|
|
|
99.76% |
| Talaromyketide B |
|
|
|
|
|
|
|
|
| TAT-MKK3b |
|
|
|
|
|
|
|
|
| Tau Protein Phosphorylation-IN-1 |
|
|
|
|
|
|
|
|
| TCS 183 |
|
|
|
|
|
|
|
|
| Teneligliptin hydrobromide |
|
|
|
|
|
|
|
99.99% |
| TGF-β/Smad-IN-3 |
|
|
|
|
|
|
|
|
| TIC10g |
|
|
|
|
|
|
|
98.92% |
| TLR4/NF-κB/MAPK-IN-1 |
|
|
|
|
|
|
|
|
| TOP1288 |
|
|
|
|
|
|
|
|
| TOP1362 |
|
|
|
|
|
|
|
|
| Tpl2 Kinase Inhibitor 1 |
|
|
|
|
|
|
|
99.42% |
| Tpl2 Kinase Inhibitor 1 hydrochloride |
|
|
|
|
|
|
|
|
| TRi-1 |
|
|
|
|
|
|
|
99.69% |
| TriDAP |
|
|
|
|
|
|
|
|
| TriDAP dihydrochloride |
|
|
|
|
|
|
|
98.65% |
| Triphenyl phosphate-d15 |
|
|
|
|
|
|
|
99.55% |
| UM-164 |
|
|
|
|
|
|
|
98.69% |
| Umckalin |
|
|
|
|
|
|
|
|
| UNC1062 |
|
|
|
|
|
|
|
98.92% |
| Undecane |
|
|
|
|
|
|
|
99.66% |
| Undecane-d24 |
|
|
|
|
|
|
|
|
| UR241-2 |
|
|
|
|
|
|
|
99.68% |
| Urolithin M5 |
|
|
|
|
|
|
|
97.31% |
| Vacquinol-1 |
|
|
|
|
|
|
|
99.33% |
| Vacquinol-1 dihydrochloride |
|
|
|
|
|
|
|
99.70% |
| Velutin |
|
|
|
|
|
|
|
98.60% |
| Vitexin-4''-O-glucoside |
|
|
|
|
|
|
|
99.86% |
| VX-702 |
|
|
|
|
|
|
|
99.69% |
| WEIZ-WX-04-008 |
|
|
|
|
|
|
|
|
| Withangulatin A |
|
|
|
|
|
|
|
99.76% |
| Withaphysalin A |
|
|
|
|
|
|
|
98% |
| WMJ-J-09 |
|
|
|
|
|
|
|
98.44% |
| XST-14 |
|
|
|
|
|
|
|
99.26% |
| YS110 |
|
|
|
|
|
|
|
99.75% |
| Z16078526 |
|
|
|
|
|
|
|
98.12% |
| ZAK-IN-2 |
|
|
|
|
|
|
|
|
| Zaltoprofen sulfoxide |
|
|
|
|
|
|
|
|
| ZEB85 |
|
|
|
|
|
|
|
96.3985% |
| ZINC-1000507824 |
|
|
|
|
|
|
|
|
| ZJK-807 |
|
|
|
|
|
|
|
|
| α-Neoendorphin (porcine) |
|
|
|
|
|
|
|
|
| β-Funaltrexamine |
|
|
|
|
|
|
|
|
| β-Funaltrexamine hydrochloride |
|
|
|
|
|
|
|
99.07% |
| Gamma-glutamylcysteine |
|
|
|
|
|
|
|
98.53% |
| Gamma-glutamylcysteine TFA |
|
|
|
|
|
|
|
96.68% |
| Butylphthalide |
|
|
|
|
|
|
|
99.98% |
| Notoginsenoside Ft1 |
|
|
|
|
|
|
|
99.49% |
| Sodium acetate trihydrate, 99.5% |
|
|
|
|
|
|
|
99.99% |
| Sericin |
|
|
|
|
|
|
|
0% |
| Paeonolide |
|
|
|
|
|
|
|
99.89% |
| Lercanidipine |
|
|
|
|
|
|
|
99.93% |
| Ethalfluralin |
|
|
|
|
|
|
|
|
| Dihydrocaffeic acid |
|
|
|
|
|
|
|
99.86% |
| Dihydrorotenone |
|
|
|
|
|
|
|
99.66% |
| Diminazene |
|
|
|
|
|
|
|
|
| Hypaphorine |
|
|
|
|
|
|
|
99.97% |
| High density lipoprotein (human) |
|
|
|
|
|
|
|
|
| Talmapimod |
|
|
|
|
|
|
|
98.68% |
| Talmapimod hydrochloride |
|
|
|
|
|
|
|
|
| Lumichrome |
|
|
|
|
|
|
|
99.84% |
| Crebanine |
|
|
|
|
|
|
|
99.83% |
| Clifutinib |
|
|
|
|
|
|
|
99.59% |
| Gaultherin |
|
|
|
|
|
|
|
99.44% |
| Ononin |
|
|
|
|
|
|
|
99.97% |
| Pteryxin |
|
|
|
|
|
|
|
99.55% |
| Carbimazole-d3 |
|
|
|
|
|
|
|
|
| Carbimazole |
|
|
|
|
|
|
|
98.0% |
| Flavokawain A |
|
|
|
|
|
|
|
99.73% |
| Cavidine |
|
|
|
|
|
|
|
|
| Demethyleneberberine |
|
|
|
|
|
|
|
|
| Dehydromiltirone |
|
|
|
|
|
|
|
99.11% |
| Dehydrocostus Lactone |
|
|
|
|
|
|
|
99.98% |
| Bicyclol |
|
|
|
|
|
|
|
99.91% |
| Bisphenol A-13C12 |
|
|
|
|
|
|
|
96.38% |
| Bisphenol A |
|
|
|
|
|
|
|
99.91% |
| Fumaric acid |
|
|
|
|
|
|
|
99.91% |
| Semaglutide-d8 |
|
|
|
|
|
|
|
99.88% |
| Gemcitabine |
|
|
|
|
|
|
|
99.95% |
| Indoprofen |
|
|
|
|
|
|
|
99.36% |
| Caudatin |
|
|
|
|
|
|
|
99.95% |
| Tetraacetylphytosphingosine |
|
|
|
|
|
|
|
99.90% |
| (±)-Stylopine |
|
|
|
|
|
|
|
99.86% |
| Tubeimoside I |
|
|
|
|
|
|
|
99.96% |
| Orcinol |
|
|
|
|
|
|
|
99.97% |
| Kukoamine B |
|
|
|
|
|
|
|
99.87% |
| Kukoamine B-d5 dihydrochloride |
|
|
|
|
|
|
|
|
| Rehmannioside A |
|
|
|
|
|
|
|
99.95% |
| Ceftiofur |
|
|
|
|
|
|
|
99.81% |
| Ceftiofur hydrochloride |
|
|
|
|
|
|
|
98.43% |
| Ceftiofur sodium |
|
|
|
|
|
|
|
98.02% |
| Ceftiofur-d3 sodium |
|
|
|
|
|
|
|
|
| Oxatomide |
|
|
|
|
|
|
|
98.11% |
| Fumaric acid disodium |
|
|
|
|
|
|
|
99.98% |
| p-Cresyl sulfate |
|
|
|
|
|
|
|
99.98% |
| p-Cresyl sulfate potassium |
|
|
|
|
|
|
|
99.97% |
| p-Cresol sulfate-d4 potassium |
|
|
|
|
|
|
|
|
| Cornuside |
|
|
|
|
|
|
|
99.99% |
| Asperosaponin VI |
|
|
|
|
|
|
|
99.62% |
| Peramivir |
|
|
|
|
|
|
|
99.94% |
| Peramivir trihydrate |
|
|
|
|
|
|
|
98.30% |
| Isomaltulose monohydrate |
|
|
|
|
|
|
|
|
| Hederacoside C |
|
|
|
|
|
|
|
99.92% |
| Duligotuzumab |
|
|
|
|
|
|
|
99.17% |
| Dilmapimod |
|
|
|
|
|
|
|
99.56% |
| Isoscopoletin |
|
|
|
|
|
|
|
99.92% |
| Isosinensetin |
|
|
|
|
|
|
|
99.90% |
| Isoacteoside |
|
|
|
|
|
|
|
99.73% |
| Isosilybin A |
|
|
|
|
|
|
|
99.63% |
| Angelicin |
|
|
|
|
|
|
|
99.98% |
| Isoastragaloside I |
|
|
|
|
|
|
|
99.49% |
| Gomisin D |
|
|
|
|
|
|
|
99.56% |
| Tropisetron |
|
|
|
|
|
|
|
99.93% |
| Tropisetron-d5 |
|
|
|
|
|
|
|
|
| Dinitramine |
|
|
|
|
|
|
|
|
| Cantharidic acid |
|
|
|
|
|
|
|
|
| Acenocoumarol-d4 |
|
|
|
|
|
|
|
|
| Acenocoumarol-d5 |
|
|
|
|
|
|
|
|
| Acenocoumarol |
|
|
|
|
|
|
|
99.17% |
| Neoandrographolide |
|
|
|
|
|
|
|
99.41% |
| Neomangiferin |
|
|
|
|
|
|
|
99.80% |
| Flavanone |
|
|
|
|
|
|
|
99.73% |
| Armepavine |
|
|
|
|
|
|
|
99.19% |
| (+)-Eudesmin |
|
|
|
|
|
|
|
99.91% |
| Citropten |
|
|
|
|
|
|
|
99.69% |
| Pectolinarigenin |
|
|
|
|
|
|
|
99.98% |
| Tamarixetin |
|
|
|
|
|
|
|
98.80% |
| Vescalagin |
|
|
|
|
|
|
|
|
| Roburic acid |
|
|
|
|
|
|
|
99.93% |
| Platycodin D3 |
|
|
|
|
|
|
|
98.91% |
| Hesperetin |
|
|
|
|
|
|
|
99.12% |
| Hesperetin-d3 |
|
|
|
|
|
|
|
|
| Picolinafen |
|
|
|
|
|
|
|
|
| Fulvestrant (S enantiomer) |
|
|
|
|
|
|
|
|
| Teneligliptin hydrobromide hydrate |
|
|
|
|
|
|
|
99.97% |
| Darifenacin hydrobromide |
|
|
|
|
|
|
|
99.78% |
| Nickel(II) oxide |
|
|
|
|
|
|
|
|
| Nitidine chloride |
|
|
|
|
|
|
|
99.82% |
| Cupric chloride |
|
|
|
|
|
|
|
|
| Tabersonine |
|
|
|
|
|
|
|
98.02% |
| Tabersonine hydrochloride |
|
|
|
|
|
|
|
98.55% |
| Silybin B |
|
|
|
|
|
|
|
99.90% |
| Saquinavir-d9 |
|
|
|
|
|
|
|
|
| Saquinavir |
|
|
|
|
|
|
|
99.77% |
| Saquinavir mesylate |
|
|
|
|
|
|
|
99.40% |
| Bisabolangelone |
|
|
|
|
|
|
|
98.94% |
| Alisol F |
|
|
|
|
|
|
|
99.89% |
| Losmapimod |
|
|
|
|
|
|
|
99.94% |
| Lysophosphatidylcholines |
|
|
|
|
|
|
|
99.9% |
| Vaccarin |
|
|
|
|
|
|
|
99.05% |
| Cycloartenol |
|
|
|
|
|
|
|
99.04% |
| Polygalasaponin F |
|
|
|
|
|
|
|
99.85% |
| Licochalcone E |
|
|
|
|
|
|
|
98.07% |
| Sorafenib tosylate |
|
|
|
|
|
|
|
99.98% |
| Pulchinenoside A |
|
|
|
|
|
|
|
98.81% |
| Byakangelicol |
|
|
|
|
|
|
|
98.66% |
| Atractylenolide II |
|
|
|
|
|
|
|
99.89% |
| Bilobetin |
|
|
|
|
|
|
|
99.71% |
| Kaempferol-3-O-glucorhamnoside |
|
|
|
|
|
|
|
99.64% |
| Saponarin |
|
|
|
|
|
|
|
99.95% |
| Lercanidipine hydrochloride |
|
|
|
|
|
|
|
99.93% |
| Desipramine-d3 |
|
|
|
|
|
|
|
|
| Desipramine-d4 |
|
|
|
|
|
|
|
98.93% |
| Desipramine hydrochloride |
|
|
|
|
|
|
|
99.76% |
| Mianserin hydrochloride |
|
|
|
|
|
|
|
99.95% |
| Mianserin-d3 (hydrochloride) |
|
|
|
|
|
|
|
97.51% |
| Dehydrocorydaline chloride |
|
|
|
|
|
|
|
99.75% |
| Cyproheptadine hydrochloride sesquihydrate |
|
|
|
|
|
|
|
99.74% |
| Phellodendrine chloride |
|
|
|
|
|
|
|
99.68% |
| Dendrobine |
|
|
|
|
|
|
|
99.92% |
| Dehydrocorydaline nitrate |
|
|
|
|
|
|
|
99.89% |
| Sertaconazole nitrate |
|
|
|
|
|
|
|
99.19% |
| Chondroitin sulfate (from chicken) |
|
|
|
|
|
|
|
99.61% |
| Triphenyl phosphate |
|
|
|
|
|
|
|
98.0% |
| Esculin |
|
|
|
|
|
|
|
99.85% |
| Esculin sesquihydrate |
|
|
|
|
|
|
|
98.80% |
| Asiaticoside |
|
|
|
|
|
|
|
99.67% |
| Mianserin |
|
|
|
|
|
|
|
99.42% |
| Skatole-d3 |
|
|
|
|
|
|
|
99.10% |
| Skatole-d8 |
|
|
|
|
|
|
|
98.50% |
| Skatole-13C6 |
|
|
|
|
|
|
|
|
| Skatole |
|
|
|
|
|
|
|
99.92% |
| Bromuconazole |
|
|
|
|
|
|
|
|
| Sorafenib |
|
|
|
|
|
|
|
99.84% |
| Semaglutide |
|
|
|
|
|
|
|
99.74% |
| Semaglutide-13C6,15N TFA |
|
|
|
|
|
|
|
96.04% |
| Semaglutide TFA |
|
|
|
|
|
|
|
99.74% |
| Corynoline |
|
|
|
|
|
|
|
98.84% |
| Viridicatol |
|
|
|
|
|
|
|
99.93% |
| Nalmefene-d4 |
|
|
|
|
|
|
|
|
| Histamine |
|
|
|
|
|
|
|
99.99% |
| Histamine phosphate |
|
|
|
|
|
|
|
99.34% |
| Gynostemma Extract |
|
|
|
|
|
|
|
99.92% |
| Gypenoside L |
|
|
|
|
|
|
|
99.89% |
| Vesencumab |
|
|
|
|
|
|
|
99.34% |
| Vicenin 3 |
|
|
|
|
|
|
|
99.90% |
| Rohitukine |
|
|
|
|
|
|
|
|
| Mogroside III-E |
|
|
|
|
|
|
|
99.30% |
| Roxithromycin |
|
|
|
|
|
|
|
99.86% |
| Madecassoside |
|
|
|
|
|
|
|
99.58% |
| Pulegone-d8 |
|
|
|
|
|
|
|
|
| Pulegone |
|
|
|
|
|
|
|
99.57% |
| Dehydrodiisoeugenol |
|
|
|
|
|
|
|
99.98% |
| Dehydrocorydaline |
|
|
|
|
|
|
|
98.42% |
| Sertaconazole |
|
|
|
|
|
|
|
99.42% |
| Icrucumab |
|
|
|
|
|
|
|
99.9% |
| Sesamolin |
|
|
|
|
|
|
|
98.51% |
| Keracyanin chloride |
|
|
|
|
|
|
|
99.90% |
| Isoliquiritin apioside |
|
|
|
|
|
|
|
99.49% |
| Sotetsuflavone |
|
|
|
|
|
|
|
|
| Orcinol glucoside |
|
|
|
|
|
|
|
98.92% |
| Benzanthrone |
|
|
|
|
|
|
|
99.69% |
| Benzoylaconine |
|
|
|
|
|
|
|
99.92% |
| Benzoylpaeoniflorin |
|
|
|
|
|
|
|
98.47% |
| Solanesol |
|
|
|
|
|
|
|
98.0% |
| Liensinine |
|
|
|
|
|
|
|
99.97% |
| Liensinine Diperchlorate |
|
|
|
|
|
|
|
99.96% |
| Cucurbitacin IIa |
|
|
|
|
|
|
|
99.90% |
| Arvenin I |
|
|
|
|
|
|
|
89.41% |
| Crocetin |
|
|
|
|
|
|
|
98.07% |
| Balanophonin |
|
|
|
|
|
|
|
|
| Hellebrigenin |
|
|
|
|
|
|
|
99.69% |
| Bakuchiol |
|
|
|
|
|
|
|
98.08% |
| Schizophyllan |
|
|
|
|
|
|
|
|
| Chicanine |
|
|
|
|
|
|
|
99.96% |
| Edpetiline |
|
|
|
|
|
|
|
99.81% |
| Peimine |
|
|
|
|
|
|
|
99.9% |
| Peiminine |
|
|
|
|
|
|
|
99.89% |
| Aspirin DL-lysine |
|
|
|
|
|
|
|
|
| Plantamajoside |
|
|
|
|
|
|
|
99.80% |
| Daporinad |
|
|
|
|
|
|
|
99.91% |
| Daporinad hydrochloride |
|
|
|
|
|
|
|
|
| Darifenacin |
|
|
|
|
|
|
|
99.81% |
| Doramapimod |
|
|
|
|
|
|
|
99.93% |
| Doramapimod (GMP) |
|
|
|
|
|
|
|
|
| Doramapimod hydrochloride |
|
|
|
|
|
|
|
98.29% |
| Ergosterol peroxide |
|
|
|
|
|
|
|
99.57% |
| Varenicline Tartrate |
|
|
|
|
|
|
|
99.96% |
| Jujuboside B |
|
|
|
|
|
|
|
99.92% |
| Physalin B |
|
|
|
|
|
|
|
97.20% |
| Paris saponin VII |
|
|
|
|
|
|
|
99.84% |
| Rhoifolin |
|
|
|
|
|
|
|
99.25% |
| Eupalinolide B |
|
|
|
|
|
|
|
99.27% |
| Rotundic acid |
|
|
|
|
|
|
|
98.41% |
| Continentalic acid |
|
|
|
|
|
|
|
99.72% |
| Aspirin-d3 |
|
|
|
|
|
|
|
99.84% |
| Aspirin-d4 |
|
|
|
|
|
|
|
98.41% |
| Aspirin-d7 |
|
|
|
|
|
|
|
|
| Aspirin |
|
|
|
|
|
|
|
99.67% |
| Afatinib |
|
|
|
|
|
|
|
99.92% |
| Afatinib dimaleate |
|
|
|
|
|
|
|
99.74% |
| Coniferyl ferulate |
|
|
|
|
|
|
|
98.73% |
| Ferulic acid methyl ester |
|
|
|
|
|
|
|
99.92% |
| Bullatine A |
|
|
|
|
|
|
|
98.0% |
| Rafoxanide |
|
|
|
|
|
|
|
98.60% |
| 7,8-Dimethoxycoumarin |
|
|
|
|
|
|
|
99.75% |
| Lumretuzumab |
|
|
|
|
|
|
|
≥99.0% |
| Bruceine A |
|
|
|
|
|
|
|
99.89% |
| Ergothioneine |
|
|
|
|
|
|
|
99.98% |
| Flavokawain B |
|
|
|
|
|
|
|
99.99% |
| Aflatoxin G1 |
|
|
|
|
|
|
|
99.67% |
| Phellodendrine |
|
|
|
|
|
|
|
|
| Coptisine |
|
|
|
|
|
|
|
|
| Coptisine Sulfate |
|
|
|
|
|
|
|
99.37% |
| Sinigrin |
|
|
|
|
|
|
|
99.92% |
| Sinigrin hydrate |
|
|
|
|
|
|
|
99.92% |
| (E/Z)-Sinigrin free base |
|
|
|
|
|
|
|
|
| Rhamnocitrin |
|
|
|
|
|
|
|
99.29% |
| Hecogenin acetate |
|
|
|
|
|
|
|
98.57% |